Prosecution Insights
Last updated: April 19, 2026

Spectrum Pharmaceuticals Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18177787 METHODS FOR PROMOTING ANTI-TUMOR IMMUNE RESPONSE IN A SUBJECT IN NEED THEREOF USING ENCAPSULATED INTERLEUKIN 12 BELYAVSKYI, MICHAIL A 1644 Non-Final OA Mar 03, 2023
17781639 METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX MACFARLANE, STACEY NEE 1675 Non-Final OA Jun 01, 2022
17637304 Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof AEDER, SEAN E 1642 Non-Final OA Feb 22, 2022

Managing Spectrum Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month